LONDON, April 22 /PRNewswire/ --

- Prestigious UK Accolade Highlights the Outstanding Innovation at the Heart of Thomson Pharma(R)

Thomson Reuters, the world's leading source of intelligent information for businesses and professionals, announced that on the occasion of the Queen's birthday it has been awarded a Queen's Award for Enterprise in the Innovation category. The award acknowledges the outstanding innovation involved in designing Thomson Pharma, the essential information solution for the pharmaceutical industry.

Thomson Reuters was chosen to receive the award because of its innovation in designing and developing Thomson Pharma, the comprehensive global pharmaceutical information solution that covers the entire drug discovery and development pipeline. Thomson Pharma delivers customers the information they need to support every aspect of drug research, development and commercialization -- from the first actions of drug discovery to testing, improving and launching new drugs.

Designed over a period of two years, Thomson Pharma had the specific goal of providing the pharmaceutical industry with comprehensive information, drawn from more than 40 separate sources, and delivered on a simple, flexible fully-integrated system using cutting-edge digital technologies. Following an intense design process which included multiple consultations with existing and potential customers, Thomson Pharma was unveiled in 2004 to great success.

"Thomson Pharma is helping our customers discover new opportunities and accelerate the development of new drugs and therapies," said Jon Brett Harris, EVP Pharmaceutical and Chemicals Markets, Thomson Reuters. "We are proud to be directly contributing to improving research and development productivity and ultimately to improvements in quality of life."

The Scientific business of Thomson Reuters provides information and knowledge to accelerate research, discovery and innovation. Our authoritative, accurate and timely information is essential for drug companies to discover new drugs and get them to market faster; researchers to find relevant papers and know what's newly published in their subject; and businesses to optimize their intellectual property and find competitive intelligence. We create the research platforms and services of the future that will power our customers toward business and personal success.

About Thomson Reuters

Thomson Reuters is the world's leading source of intelligent information for businesses and professionals. We combine industry expertise with innovative technology to deliver critical information to leading decision makers in the financial, legal, tax and accounting, scientific, healthcare and media markets, powered by the world's most trusted news organization. With headquarters in New York and major operations in London and Eagan, Minnesota, Thomson Reuters employs more than 50,000 people in 93 countries. Thomson Reuters shares are listed on the New York Stock Exchange (NYSE: TRI); Toronto Stock Exchange (TSX: TRI); London Stock Exchange (LSE: TRIL); and Nasdaq (Nasdaq: TRIN). For more information, go to www.thomsonreuters.com.

Web site: http://www.thomsonreuters.com

Eoin Bedford, PR Manager, Scientific, +44-207-433-4691, eoin.bedford@thomsonreuters.com